Compare Adobe Systems Inc (ADBE) vs AstraZeneca plc (AZN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adobe Systems Inc vs AstraZeneca plc — how do they compare? Adobe Systems Inc trades at $219.2 (market cap $88.06B), while AstraZeneca plc trades at $189.57 (market cap $294.08B). The key difference: AstraZeneca plc is far larger — about 3.3× Adobe Systems Inc's market cap, and AstraZeneca plc pays a 1.64% dividend while Adobe Systems Inc pays none. Which is the better fit depends on your goals.
| ADBE | AZN | |
|---|---|---|
Market Cap | $88.06B | $294.08B |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $382.24 | $209.48 |
52-Week Low | $193.41 | $137.44 |
Enterprise Value | $89.50B | $320.32B |
Dividend Yield | — | 1.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Adobe (ADBE) trades at $221.54, up 1.59% today, with a bullish technical signal despite near-term overbought RSI conditions. The company reported strong Q1 2026 earnings, beating EPS estimates with $5.96 vs. $5.82 expected. Revenue grew to $23.77B in 2025, with net income margin expanding to 29.99%. However, negative net cash flow of -$2.18B in 2025 and rising debt-to-asset ratio to 18.61% highlight financial pressures.
Outlook remains positive with analyst consensus price target of $246.75 (11.4% upside), but AI competition and CEO transition risks weigh on sentiment. Institutional buying continues, yet legal scrutiny and sector volatility pose near-term challenges. Valuation metrics like P/E of 12.67 and EV/EBITDA of 8.83 suggest relative undervaluation versus peers if growth sustains.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adobe Systems Inc
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →
